Scarica l'app Stockscreener
1.60
3.67%
-0.05
Precedente Chiudi:
$1.65
Aprire:
$1.54
Volume 24 ore:
403.49K
Relative Volume:
0.08
Capitalizzazione di mercato:
$51.17M
Reddito:
-
Utile/perdita netta:
$-16.14M
Rapporto P/E:
-2.963
EPS:
-0.54
Flusso di cassa netto:
$-3.99M
1 W Prestazione:
+11.93%
1M Prestazione:
+16.87%
6M Prestazione:
-40.91%
1 anno Prestazione:
-68.65%
Intervallo 1D:
$1.53
$1.60
Intervallo di 1 settimana:
$1.53
$2.091
Portata 52W:
$1.12
$7.0791
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
Nome
Telomir Pharmaceuticals Inc
Settore
Industria
Telefono
786-396-6723
Indirizzo
100 SE 2ND ST, MIAMI
Confronta TELO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TELO
Telomir Pharmaceuticals Inc
|
1.585 | 55.82M | 0 | -16.14M | -3.99M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.70 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.07 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.97 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
328.26 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-21 | Iniziato | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc Borsa (TELO) Ultime notizie
Tools to assess Telomir Pharmaceuticals Inc.’s risk profileWeekly Risk Report & AI Forecasted Entry and Exit Points - newser.com
What to do if you’re stuck in Telomir Pharmaceuticals Inc.July 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com
Why Telomir Pharmaceuticals Inc. is moving todayMarket Rally & Free Community Supported Trade Ideas - newser.com
Telomir Pharmaceuticals Inc Stock Analysis and ForecastLong-Term Investment Plans & Download Our Free Trading Blueprint - earlytimes.in
What drives Telomir Pharmaceuticals Inc stock priceIndustrial Stocks Review & Free Transform Portfolio With Stocks - earlytimes.in
Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Re - Shreveport Times
Why Telomir Pharmaceuticals Stock Is Rising 40% Premarket Today - Stocktwits
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells - DelmarvaNow.com
Institutional scanner results for Telomir Pharmaceuticals Inc.2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
How to monitor Telomir Pharmaceuticals Inc. with trend dashboardsJuly 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Why Is Telomir Pharmaceuticals Stock Trading Higher Today?Telomir Pharmaceuticals (NASDAQ:TELO) - Benzinga
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Targets Additional Histone Demethylase Families, a Unique Profile in Cancer and Aging Not Seen in Other Therapies - The Florida Times-Union
Telomir stock soars after drug shows promise against aggressive breast cancer - Investing.com
Telomir Pharma’s Cutting-Edge Cancer Breakthrough - StocksToTrade
Telomir’s Investigational Therapy: A Game Changer? - timothysykes.com
Pre-Market Titans: TTRX, BJDX & UPC Set The Pace - RTTNews
Telomir-1 shows promise against triple-negative breast cancer By Investing.com - Investing.com South Africa
Selective killing of aggressive TNBC cells: Telomir's Telomir‑1 disrupts iron-driven energy and mitochondrial function - Stock Titan
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - inkl
Weiss Ratings Reiterates “Sell (E+)” Rating for Telomir Pharmaceuticals (NASDAQ:TELO) - Defense World
Telomir Pharmaceuticals Telomir-1 selectively kills aggressive triple-negative breast cancer cells - MarketScreener
Telomir Pharmaceuticals Unveils Promising Cancer Treatment Discovery - TipRanks
Telomir shares surge after breakthrough tumor suppressor gene reactivation data - MSN
Telomir stock soars after tumor suppressor gene reactivation results - Investing.com
Stock Market Today: Dow Jones, Nasdaq 100, S&P 500 Futures Turn Green—Trilogy Metals, AMD, Applovin In Focus (UPDATED) - Benzinga
Morning Market Movers: SPRB, LXEO, BMEA, Seeing Big Swings - RTTNews
Telomir Says Investigational Therapy Reactivates Tumor Suppressor Genes in Preclinical Models - MarketScreener
Telomir-1 shows promise in reactivating tumor suppressor genes By Investing.com - Investing.com Nigeria
Telomir-1 shows promise in reactivating tumor suppressor genes - Investing.com
Telomir Telomir-1 Resets DNA Methylation of MASPIN, RASSF1A | TELO Stock News - Stock Titan
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Sees Significant Decrease in Short Interest - Defense World
McCormick, Telomir Pharmaceuticals And 3 Stocks To Watch Heading Into Tuesday - Benzinga
TELO, PCSA, RVPH, NMTC, BRTX Jump In After-Hours Trading On Light News Flow And Select Updates - RTTNews
Telomir Pharmaceuticals Inc Azioni (TELO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.07%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):